211 related articles for article (PubMed ID: 32253501)
21. Diminished white matter integrity in patients with systemic lupus erythematosus.
Schmidt-Wilcke T; Cagnoli P; Wang P; Schultz T; Lotz A; Mccune WJ; Sundgren PC
Neuroimage Clin; 2014; 5():291-7. PubMed ID: 25161895
[TBL] [Abstract][Full Text] [Related]
22. Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature.
Balci MA; Pamuk GE; Unlu E; Usta U; Pamuk ON
Lupus; 2017 Oct; 26(11):1224-1227. PubMed ID: 28152659
[TBL] [Abstract][Full Text] [Related]
23. EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
Gandhi MK; Hoang T; Law SC; Brosda S; O'Rourke K; Tobin JWD; Vari F; Murigneux V; Fink L; Gunawardana J; Gould C; Oey H; Bednarska K; Delecluse S; Trappe RU; Merida de Long L; Sabdia MB; Bhagat G; Hapgood G; Blyth E; Clancy L; Wight J; Hawkes E; Rimsza LM; Maguire A; Bojarczuk K; Chapuy B; Keane C
Blood; 2021 Mar; 137(11):1468-1477. PubMed ID: 33202420
[TBL] [Abstract][Full Text] [Related]
24. Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B-cell immunomodulation in antibody-mediated diseases.
Modica RF; Thatayatikom A; Bell-Brunson DH; Elder ME
Clin Rheumatol; 2023 Jul; 42(7):1965-1979. PubMed ID: 36971919
[TBL] [Abstract][Full Text] [Related]
25. Echolalia as a novel manifestation of neuropsychiatric systemic lupus erythematosus.
Zapor M; Murphy FT; Enzenauer R
South Med J; 2001 Jan; 94(1):70-2. PubMed ID: 11213948
[TBL] [Abstract][Full Text] [Related]
26. Management of non-renal non-neurologic persistent lupus activity in real world patients from Argentina.
Scolnik M; Scaglioni V; Pons-Estel GJ; Soriano ER
Lupus; 2019 Aug; 28(9):1167-1173. PubMed ID: 31299882
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.
Tokunaga M; Saito K; Kawabata D; Imura Y; Fujii T; Nakayamada S; Tsujimura S; Nawata M; Iwata S; Azuma T; Mimori T; Tanaka Y
Ann Rheum Dis; 2007 Apr; 66(4):470-5. PubMed ID: 17107983
[TBL] [Abstract][Full Text] [Related]
28. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Löfström B; Backlin C; Sundström C; Ekbom A; Lundberg IE
Ann Rheum Dis; 2007 Dec; 66(12):1627-32. PubMed ID: 17517757
[TBL] [Abstract][Full Text] [Related]
29. Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence.
Narváez J; Ríos-Rodriguez V; de la Fuente D; Estrada P; López-Vives L; Gómez-Vaquero C; Nolla JM
Semin Arthritis Rheum; 2011 Dec; 41(3):364-72. PubMed ID: 21875742
[TBL] [Abstract][Full Text] [Related]
30. Cerebral large vessel vasculitis in systemic lupus erythematosus.
Böckle BC; Jara D; Aichhorn K; Junker D; Berger T; Ratzinger G; Sepp NT
Lupus; 2014 Nov; 23(13):1417-21. PubMed ID: 24969082
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
32. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
[TBL] [Abstract][Full Text] [Related]
33. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus.
Tamashiro LF; Oliveira RD; Oliveira R; Frota ER; Donadi EA; Del-Ben CM; Teixeira AL; Louzada-Junior P
Rheumatology (Oxford); 2014 Dec; 53(12):2182-90. PubMed ID: 24942492
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management.
Postal M; Costallat LT; Appenzeller S
CNS Drugs; 2011 Sep; 25(9):721-36. PubMed ID: 21870886
[TBL] [Abstract][Full Text] [Related]
35. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract][Full Text] [Related]
36. [Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].
Lefèvre G; Zéphir H; Warembourg F; Michelin E; Pruvo JP; Hachulla E; Semah F; Dubucquoi S; Lenfant P; Vermersch P; Hatron PY; Prin L; Launay D
Rev Med Interne; 2012 Sep; 33(9):491-502. PubMed ID: 22579860
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).
Hermosillo-Romo D; Brey RL
Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):229-44. PubMed ID: 12041951
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychiatric systemic lupus erythematosus among Nigerians.
Adelowo OO; Oguntona AS; Ojo O
Afr J Med Med Sci; 2009 Mar; 38(1):33-8. PubMed ID: 19722426
[TBL] [Abstract][Full Text] [Related]
39. A clinicopathological study of primary central nervous system lymphomas & their association with Epstein-Barr virus.
Sharma MC; Gupta RK; Kaushal S; Suri V; Sarkar C; Singh M; Kale SS; Sahoo RK; Kumar L; Raina V
Indian J Med Res; 2016 May; 143(5):605-15. PubMed ID: 27488004
[TBL] [Abstract][Full Text] [Related]
40. Cerebellar ataxia as a primary manifestation of neuropsychiatric systemic lupus erythematosus.
Sy MCC; Reyes NGD; Zamora GT; Fernandez MLL
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
